A relationship between latent toxoplasmosis and the immune system during HIV disease is poorly understood. Therefore, the aim of this follow-up study was to characterize immunological parameters in HIV-infected patients with latent toxoplasmosis and noninfected individuals. A total of 101 HIV-infected patients were enrolled in the study. The patients were classified into two groups based on anti-Toxoplasma gondii antibodies: a group of 55 toxoplasma-positive persons (TP) and a group of 46 toxoplasma-negative persons (TN). Absolute counts of several lymphocyte subsets decreased in the TP group, namely, T cells (p = 0.007), B cells (p = 0.002), NK cells (p = 0.009), CD4 T cells (p = 0.028), and CD8 T cells (p = 0.004). On the other hand, the percentage of CD8 T cells expressing CD38 and HLA-DR significantly increased during the follow-up in the TP group (p = 0.003, p = 0.042, resp.) as well as the intensity of CD38 and HLA-DR expression (MFI) on CD8 T cells (p = 0.001, p = 0.057, resp.). In the TN group, analysis of the kinetics of immunological parameters revealed no significant changes over time. In conclusion, the results suggest that latent T. gondii infection modulates the immune response during HIV infection.

Department of Biostatistics National Institute of Public Health Prague Czech Republic

Department of Infectious and Tropical Diseases 1st Faculty of Medicine Charles University Prague and Na Bulovce Hospital Budínova 2 180 81 Prague Czech Republic

Department of Infectious and Tropical Diseases 1st Faculty of Medicine Charles University Prague and Na Bulovce Hospital Budínova 2 180 81 Prague Czech Republic ; Department of Infectious Diseases 1st Faculty of Medicine Charles University Prague and Military University Hospital Prague Prague Czech Republic

National Reference Laboratory for Toxoplasmosis National Institute of Public Health Prague Czech Republic

Zobrazit více v PubMed

Kodym P., Malý M., Beran O., et al. Incidence, immunological and clinical characteristics of reactivation of latent Toxoplasma gondii infection in HIV-infected patients. Epidemiology and Infection. 2015;143(3):600–607. doi: 10.1017/S0950268814001253. PubMed DOI PMC

Bachmeyer C., Mouchnino G., Thulliez P., Blum L. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation. The Journal of Infection. 2006;52(2):e55–e57. doi: 10.1016/j.jinf.2005.05.004. PubMed DOI

Meers S., Lagrou K., Theunissen K., et al. Myeloablative conditioning predisposes patients for toxoplasma gondii reactivation after allogeneic stem cell transplantation. Clinical Infectious Diseases. 2010;50(8):1127–1134. doi: 10.1086/651266. PubMed DOI

Abgrall S., Rabaud C., Costagliola D., Clinical Epidemiology Group of the French Hospital Database on HIV Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clinical Infectious Diseases. 2001;33(10):1747–1755. doi: 10.1086/322622. PubMed DOI

Israelski D. M., Chmiel J. S., Poggensee L., Phair J. P., Remington J. S. Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. Journal of Acquired Immune Deficiency Syndromes. 1993;6(4):414–418. PubMed

Dupont C. D., Christian D. A., Hunter C. A. Immune response and immunopathology during toxoplasmosis. Seminars in Immunopathology. 2012;34(6):793–813. doi: 10.1007/s00281-012-0339-3. PubMed DOI PMC

Miman O., Kusbeci O. Y., Aktepe O. C., Cetinkaya Z. The probable relation between Toxoplasma gondii and Parkinson's disease. Neuroscience Letters. 2010;475(3):129–131. doi: 10.1016/j.neulet.2010.03.057. PubMed DOI

Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. The Journal of Experimental Biology. 2013;216, part 1:127–133. doi: 10.1242/jeb.073635. PubMed DOI

Flegr J., Zitková Š., Kodym P., Frynta D. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii . Parasitology. 1996;113(1):49–54. doi: 10.1017/s0031182000066269. PubMed DOI

Lindová J., Novotná M., Havlíček J., et al. Gender differences in behavioural changes induced by latent toxoplasmosis. International Journal for Parasitology. 2006;36(14):1485–1492. doi: 10.1016/j.ijpara.2006.07.008. PubMed DOI

Shapira Y., Agmon-Levin N., Selmi C., et al. Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. Journal of Autoimmunity. 2012;39(1-2):112–116. doi: 10.1016/j.jaut.2012.01.001. PubMed DOI

Kaňková Š., Procházková L., Flegr J., Calda P., Springer D., Potluková E. Effects of latent toxoplasmosis on autoimmune thyroid diseases in pregnancy. PLoS ONE. 2014;9(10) doi: 10.1371/journal.pone.0110878.e110878 PubMed DOI PMC

Kaňková Š., Holáň V., Zajícová A., Kodym P., Flegr J. Modulation of immunity in mice with latent toxoplasmosis—the experimental support for the immunosuppression hypothesis of Toxoplasma-induced changes in reproduction of mice and humans. Parasitology Research. 2010;107(6):1421–1427. doi: 10.1007/s00436-010-2013-9. PubMed DOI

Flegr J., Stříž I. Potential immunomodulatory effects of latent toxoplasmosis in humans. BMC Infectious Diseases. 2011;11, article 274 doi: 10.1186/1471-2334-11-274. PubMed DOI PMC

Castro K. G., Ward J. W., Slutsker L., et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report. Recommendations and Reports. 1992;41(17):1–19. PubMed

Bartovská Z., Beran O., Rozsypal H., Holub M. Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on non-specific immune activation. Current HIV Research. 2011;9(2):88–94. doi: 10.2174/157016211795569078. PubMed DOI

Kodym P., Machala L., Roháčová H., Širocká B., Malý M. Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis. Clinical Microbiology and Infection. 2007;13(1):40–47. doi: 10.1111/j.1469-0691.2006.01564.x. PubMed DOI

Machala L., Malý M., Hrdá Š., Rozsypal H., Staňková M., Kodym P. Antibody response of HIV-infected patients to latent, cerebral and recently acquired toxoplasmosis. European Journal of Clinical Microbiology & Infectious Diseases. 2009;28(2):179–182. doi: 10.1007/s10096-008-0600-9. PubMed DOI

Lejeune M., Miró J. M., Lazzari E. D., et al. Restoration of T cell responses to Toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis. Clinical Infectious Diseases. 2011;52(5):662–670. doi: 10.1093/cid/ciq197. PubMed DOI

Connors M., Kovacs J. A., Krevat S., et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Medicine. 1997;3(5):533–540. doi: 10.1038/nm0597-533. PubMed DOI

Lange C. G., Valdez H., Medvik K., Asaad R., Lederman M. M. CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Clinical Immunology. 2002;102(2):154–161. doi: 10.1006/clim.2001.5164. PubMed DOI

Luft B. J., Brooks R. G., Conley F. K., McCabe R. E., Remington J. S. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. The Journal of the American Medical Association. 1984;252(7):913–917. doi: 10.1001/jama.252.7.913. PubMed DOI

Denkers E. Y., Gazzinelli R. T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews. 1998;11(4):569–588. PubMed PMC

Bhadra R., Khan I. A. Redefining chronic toxoplasmosis—a T cell exhaustion perspective. PLoS Pathogens. 2012;8(10) doi: 10.1371/journal.ppat.1002903.e1002903 PubMed DOI PMC

Khan I. A., Green W. R., Kasper L. H., Green K. A., Schwartzman J. D. Immune CD8+ T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host. Infection and Immunity. 1999;67(11):5869–5876. PubMed PMC

Gazzinelli R. T., Hakim F. T., Hieny S., Shearer G. M., Sher A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. The Journal of Immunology. 1991;146(1):286–292. PubMed

Liu Z., Cumberland W. G., Hultin L. E., Prince H. E., Detels R., Giorgi J. V. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the multicenter AIDS cohort study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1997;16(2):83–92. doi: 10.1097/00042560-199710010-00003. PubMed DOI

Beran O., Holub M., Špála J., Kalanin J., Staňková M. CD38 expression on CD8+ T cells in human immunodeficiency virus 1-positive adults treated with HAART. Acta Virologica. 2003;47(2):121–124. PubMed